MRI restaging of rectal cancer: The RAC (Response–Anal canal–CRM) analysis joint consensus guidelines of the GRERCAR and GRECCAR groups - 17/03/23
Cet article a été publié dans un numéro de la revue, cliquez ici pour y accéder
Highlights |
• | The evaluation of tumor response in rectal cancer is a challenge for the radiologist. |
• | The main features to evaluate can be summarized through the “RAC assessment: Response–Anal canal– Circumferential resection margin”. |
• | The combination of functional and morphological tumor features on MRI helps assess rectal tumor response to neoadjuvant therapy. |
• | After a near complete tumor response on MRI, another MRI evaluation at six to ten weeks is recommended to potentially propose a watch and wait approach. |
Abstract |
Purpose |
To develop guidelines by international experts to standardize data acquisition, image interpretation, and reporting in rectal cancer restaging with magnetic resonance imaging (MRI).
Materials and methods |
Evidence-based data and experts’ opinions were combined using the RAND-UCLA Appropriateness Method to attain consensus guidelines. Experts provided recommendations for reporting template and protocol for data acquisition were collected; responses were analysed and classified as “RECOMMENDED” versus “NOT RECOMMENDED” (if ≥ 80% consensus among experts) or uncertain (if < 80% consensus among experts).
Results |
Consensus regarding patient preparation, MRI sequences, staging and reporting was attained using the RAND-UCLA Appropriateness Method. A consensus was reached for each reporting template item among the experts. Tailored MRI protocol and standardized report were proposed.
Conclusion |
These consensus recommendations should be used as a guide for rectal cancer restaging with MRI.
Le texte complet de cet article est disponible en PDF.Keywords : Magnetic resonance imaging, Neoadjuvant therapy, Rectal neoplasms, Re-staging, “Watch-and-wait”
Abbreviations : ADC, CRM, ECRT, DWI, EMVI, ESGAR, FOV, GRERCAR group, GRECCAR group, LARC, MRF, MRI, NAT, T2W, TME, TNM, mrTRG
Plan
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?